IP Library Granted Patent US 12,173,365
Granted Patent B2
US 12,173,365 · App. 17/713,934 · Granted Dec 24, 2024

Sequencing using non-natural nucleotides

Inventors: Gilad Almogy (Palo Alto, CA); Linda Lee (Palo Alto, CA)
Assignee: Ultima Genomics, Inc.
C12Q1/6869C12Q1/6806
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,173,365
App. No.
17/713,934
Granted
Dec 24, 2024
Kind
B2
Abstract

The present disclosure provides methods and systems for nucleic acid sequencing. Such systems and methods may achieve context-independent incorporation, have reduced context-dependence or have context-dependence that is amenable to calibration and modeling. Such systems and methods may also reduce misincorporation.

Claims (24)

1. A method for determining a nucleic acid sequence of a target nucleic acid molecule, comprising:

(a) providing a plurality of nucleic acid molecules immobilized to a support, wherein each of said plurality of nucleic acid molecules exhibits sequence homology to said target nucleic acid molecule, and wherein said support is operatively coupled to a detector;

(b) directing a nucleotide mixture to said plurality of nucleic acid molecules immobilized to said support, which said nucleotide mixture comprises at least a first subset of nucleotide analogs and a second subset of nucleotide analogs, wherein nucleotide analogs of said first subset and said second subset are different from one another, wherein a given one of said first subset of nucleotide analogs comprises a reporter moiety and is detectable by said detector, and wherein a given one of said second subset of nucleotide analogs is not detectable by said detector;

(c) incorporating said nucleotide mixture comprising at least said first subset of nucleotide analogs and said second subset of nucleotide analogs into said plurality of nucleic acid molecules;

(d) using said detector to detect said given one of said first subset of nucleotide analogs; and

(e) repeating (c) and (d), thereby determining said nucleic acid sequence of said target nucleic acid molecule.

2. The method of claim 1 , wherein a given one of said second subset of nucleotide analogs does not comprise a reporter moiety.

3. The method of claim 2 , wherein said given one of said second subset of nucleotide analogs comprises a quencher.

4. The method of claim 1 , wherein said given one of said second subset of nucleotide analogs has structural homology of 85% or more with respect to said given one of said first subset of nucleotide analogs.

5. The method of claim 1 , wherein said nucleotide mixture further comprises naturally occurring nucleotides.

6. The method of claim 5 , wherein said naturally occurring nucleotides are selected from the group consisting of adenine-containing nucleotides, thymine-containing nucleotides, cytosine-containing nucleotides, guanine-containing nucleotides, and uracil-containing nucleotides.

7. The method of claim 1 , wherein said reporter moiety is a fluorophore.

8. The method of claim 1 , wherein during incorporation, said given one of said first subset of nucleotide analogs and said given one of said second subset of nucleotide analogs are indistinguishable by an enzyme facilitating said incorporation.

9. The method of claim 8 , wherein said enzyme is a DNA polymerase.

10. The method of claim 8 , wherein said enzyme is mutated.

11. The method of claim 10 , wherein said mutation allows for efficient incorporation of said first subset of nucleotide analogs.

12. The method of claim 1 , wherein said first subset of nucleotide analogs are deoxyuridine-, dideoxyuridine-, deoxyguanosine-, dideoxyguanosine-, deoxyadenosine-, dideoxyadenosine-, deoxythymidine-, dideoxythymidine-, deoxycytidine-, or dideoxycytidine-based nucleotide analogs.

13. The method of claim 1 , wherein said second subset of nucleotide analogs are deoxyuridine-, dideoxyuridine-, deoxyguanosine-, dideoxyguanosine-, deoxyadenosine-, dideoxyadenosine-, deoxythymidine-, dideoxythymidine-, deoxycytidine-, or dideoxycytidine-based nucleotide analogs.

14. The method of claim 1 , wherein said nucleotide mixture further comprises a third subset of nucleotides or nucleotide analogs, wherein none of said third subset of nucleotides or nucleotide analogs comprises a reporter moiety.

15. A method for analyzing a target nucleic acid molecule, comprising (i) bringing said target nucleic acid molecule immobilized to a support in contact with a nucleotide mixture comprising a first set of nucleotide analogs and a second set of nucleotide analogs, wherein nucleotide analogs of said first set and nucleotide analogs of said second set are different nucleotide analogs but of the same canonical base type, and wherein nucleotide analogs of said first set or said second set, but not both, are detectable, and (ii) detecting one or more signals from said target nucleic acid molecule, thereby determining at least a portion of a nucleic acid sequence of said target nucleic acid molecule.

16. The method of claim 15 , wherein a sum of said first set of nucleotide analogs and said second set of nucleotide analogs is at least 80% of said nucleotide mixture.

17. The method of claim 16 , wherein said sum is at least 97% of said nucleotide mixture.

18. The method of claim 15 , wherein said nucleotide mixture further comprises naturally occurring nucleotides.

19. The method of claim 18 , wherein said naturally occurring nucleotides are selected from the group consisting of adenine-containing nucleotides, thymine-containing nucleotides, cytosine-containing nucleotides, guanine-containing nucleotides, and uracil-containing nucleotides.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2026
From: ULTIMA GENOMICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075435/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2022
From: ALMOGY, GILAD; LEE, LINDA
To: ULTIMA GENOMICS, INC.
Reel/Frame 059508/0524 →
Continuity (5)
Continuation 16683841 · Nov 14, 2019
Continuation PCTUS2018033517 · May 18, 2018
Provisional Application 62633942 · Feb 22, 2018
Provisional Application 62508042 · May 18, 2017
Related Publication 20230022124A1 · Jan 26, 2023